том 54 издание 6 страницы 642-646

Developing the Optimal Synthetic Schem for the Potential Nootropic Drug GZK-111, N-Phenylacetylglycyl-L-Proline Ethyl Ester

Тип публикацииJournal Article
Дата публикации2020-09-28
scimago Q4
wos Q4
БС3
SJR0.219
CiteScore1.4
Impact factor1.0
ISSN0091150X, 15739031
Drug Discovery
Pharmacology
Краткое описание
The optimal synthetic scheme for the potential nootropic drug GZK-111 (N-phenylacetylglycyl-L-proline ethyl ester) was developed. Three synthetic schemes were tested, each of which included the following steps: 1) esterification of L-proline; 2) preparation of N-phenylacetylglycine; 3) formation of the peptide bond. Esterification of proline per Brenner and preparation of N-phenylacetylglycine via acylation of glycine with phenylacetyl chloride under Schotten—Baumann conditions were used in all synthetic schemes. Three methods for forming the peptide bond between N-phenylacetylglycine and the proline ester were tried (mixed anhydride under Anderson conditions, activated benzotriazole ester, and activated succinimide ester methods) and showed that the mixed anhydride method was optimal, giving a total yield of 42%.
Найдено 
Найдено 

Топ-30

Журналы

1
Pharmaceutical Chemistry Journal
1 публикация, 50%
Pharmacokinetics and Pharmacodynamics (Farmakokinetika i farmakodinamika)
1 публикация, 50%
1

Издатели

1
Springer Nature
1 публикация, 50%
Publishing House OKI
1 публикация, 50%
1
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
2
Поделиться
Цитировать
ГОСТ |
Цитировать
KUZNETSOVA E. et al. Developing the Optimal Synthetic Schem for the Potential Nootropic Drug GZK-111, N-Phenylacetylglycyl-L-Proline Ethyl Ester // Pharmaceutical Chemistry Journal. 2020. Vol. 54. No. 6. pp. 642-646.
ГОСТ со всеми авторами (до 50) Скопировать
KUZNETSOVA E., Kolyasnikova K. N., Golubyatnikova A. K., Rebeko A. G., Gudasheva T. A. Developing the Optimal Synthetic Schem for the Potential Nootropic Drug GZK-111, N-Phenylacetylglycyl-L-Proline Ethyl Ester // Pharmaceutical Chemistry Journal. 2020. Vol. 54. No. 6. pp. 642-646.
RIS |
Цитировать
TY - JOUR
DO - 10.1007/s11094-020-02251-6
UR - https://doi.org/10.1007/s11094-020-02251-6
TI - Developing the Optimal Synthetic Schem for the Potential Nootropic Drug GZK-111, N-Phenylacetylglycyl-L-Proline Ethyl Ester
T2 - Pharmaceutical Chemistry Journal
AU - KUZNETSOVA, E.A.
AU - Kolyasnikova, K N
AU - Golubyatnikova, A K
AU - Rebeko, A G
AU - Gudasheva, T. A.
PY - 2020
DA - 2020/09/28
PB - Springer Nature
SP - 642-646
IS - 6
VL - 54
SN - 0091-150X
SN - 1573-9031
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2020_KUZNETSOVA,
author = {E.A. KUZNETSOVA and K N Kolyasnikova and A K Golubyatnikova and A G Rebeko and T. A. Gudasheva},
title = {Developing the Optimal Synthetic Schem for the Potential Nootropic Drug GZK-111, N-Phenylacetylglycyl-L-Proline Ethyl Ester},
journal = {Pharmaceutical Chemistry Journal},
year = {2020},
volume = {54},
publisher = {Springer Nature},
month = {sep},
url = {https://doi.org/10.1007/s11094-020-02251-6},
number = {6},
pages = {642--646},
doi = {10.1007/s11094-020-02251-6}
}
MLA
Цитировать
KUZNETSOVA, E.A., et al. “Developing the Optimal Synthetic Schem for the Potential Nootropic Drug GZK-111, N-Phenylacetylglycyl-L-Proline Ethyl Ester.” Pharmaceutical Chemistry Journal, vol. 54, no. 6, Sep. 2020, pp. 642-646. https://doi.org/10.1007/s11094-020-02251-6.